VISION 2020 has published a pathway for children and young people with vision impairment. It is a best practice, generic pathway that requires health, social care, education and the voluntary sector to work collaboratively to meet the needs of the child or young person and their family. The pathway is designed to be applicable for all UK countries.
Following NICE recommendations, patients with Crohn’s disease will have routine NHS access to drug ustekinumab, which offers a new way of treating the condition.
Ustekinumab (also called Stelara, manufactured by Janssen) will be available for patients with moderate to severe Crohn’s disease.
It is recommended by NICE as an option for treating the disease in adults who have had little or no response, or an intolerance to existing therapies.
Crohn’s disease is an inflammatory bowel disease, and can affect any part of the digestive system. Symptoms can include stomach cramps, diarrhoea and fatigue. It is a chronic condition which means that is it lifelong.
The Community Pharmacy Patient Safety Group, which provides a forum for community pharmacy organisations to openly share and learn from each other when things go wrong, has launched a new website. The group, which was originally hosted by Pharmacy Voice, considers how learning from patient safety incidents can be applied across the pharmacy network and wider NHS.
A briefing from the Centre for Mental Health reviews evidence from Care Quality Commission inspection reports of inpatient rehabilitation services in England. It finds that while many people receive high quality care close to home from rehabilitation services, a minority spend periods of many months and sometimes years in hospital. Some are placed far from home in locked wards and become isolated from their families and dislocated from their local health and care services. It calls on the government and the NHS to take action.
Primary care leaders seeking to strengthen practices at risk from workforce, demand and other pressures can access funding from NHS England’s resilience programme, part of the General Practice Forward View. The GP resilience programme recognises that many practices are already struggling to cope with existing workload for a variety of reasons, and that others are looking for long-term solutions in the face of uncertainties about the supply of GPs, funding, running costs, premises and related issues.
PCC is working with practices at all points on the spectrum from the most vulnerable to those building resilience through collaboration. This includes working with other organisations, to provide the necessary infrastructure and scale to support effective sharing of resources, workforce and expansion of services both to serve the care needs of local populations and to secure the future resources needed for long-term sustainability and growth.
To find out how we are working with practices and primary care commissioners to stabilise vulnerable practices and support GP resilience please email firstname.lastname@example.org with “GP resilience” in the subject line.